Advances in Oral Drugs for Multiple Sclerosis

Posted August 1, 2011 and tagged with fda, laquinimod, oral ms drug, oral multiple sclerosis drug, teva.

Today, Teva Pharmaceuticals had mixed reports to share regarding laquinimod, an experimental, oral drug for Multiple Sclerosis.

Click here to read more about the clinical study and other oral treatments for Multiple Sclerosis.